[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587031":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":27,"responsibleParty":47,"collaborators":11,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":11,"eligibilityCriteria":56,"healthyVolunteers":53,"sex":57,"minAge":58,"maxAge":11,"enrollmentInfo":59,"targetDuration":11,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":29,"whyStopped":11,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"All India Institute of Medical Sciences, Bhubaneswar","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CT guided biopsy","ACTIVE_COMPARATOR",null,[13],"Procedure: CT guided biopsy",{"label":15,"type":16,"description":11,"interventionNames":17},"PET-CT guided biopsy","EXPERIMENTAL",[18],"Procedure: PET-CT guided biopsy",[20,24],{"type":21,"name":15,"description":22,"armGroupLabels":23,"otherNames":11},"PROCEDURE","PET-CT guided biopsy of lung lesions",[15],{"type":21,"name":9,"description":25,"armGroupLabels":26,"otherNames":11},"CT guided biopsy of lung lesions",[9],[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"RECRUITING","Bhubaneswar","Odisha","751019","India","IN",{"type":36,"coordinates":37},"Point",[38,39],85.83385,20.27241,{"lat":39,"lon":38},[42],{"name":43,"role":44,"phone":45,"phoneExt":11,"email":46},"Dr Girish Kumar Parida, MD","CONTACT","+91 9968856817","grissh135@gmail.com",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Girish Kumar Parida","Assistant Professor","100587031","petct-guided-biopsy-versus-ct-guided-biopsy-in-evaluation-of-suspected-lung-neoplasms-100587031",false,"NCT06923098","PET\u002FCT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS","Inclusion Criteria:\n\n* Age above 18 years\n* INR \\< 1.2 and platelet counts \\> 80,000\u002Fmm3\n* CT thorax with lung lesion more than 10 mm.\n* Accessible lesions for CT-guided biopsy.\n\nExclusion Criteria:\n\n* Participants with pre-existing bleeding diathesis like hemophilia, coagulopathy defined by -INR ≥1.2 and Platelet counts ≤ 80,000\u002Fmm3\n* Participants who refuse to provide consent\n* Signs of hypoperfusion like hypotension, cyanosis etc.\n* Presence of hypoxemia with SpO2 \\\u003C 94 %- measured in a pulse oximeter)\n* Pregnant\u002FLactating female subjects\n* Non-cooperative subjects\n* Lesions that are inaccessible (decision made on pre-biopsy planning)\n* Serum creatinine level more than 2mg\u002Fdl.","ALL","18 Years",{"count":60,"type":61},108,"ESTIMATED","INTERVENTIONAL",[64],"NA","Percutaneous CT guided biopsy is a well-established, standard sampling technique for suspected neoplastic lesions located in peripheral region in lung parenchyma. Inconclusive results on CT guided biopsy is substantially higher in large lung lesions which are prone to cause peripheral pneumonia, atelectasis and even regional necrosis, which are hard to be distinguished from tumor on CT images.\n\nFunctional imaging guided biopsy like PET\u002FCT guided biopsy identifies areas of highest concentration of neoplastic cells and provides accurate results. Only a few studies have been done regarding PET\u002FCT guided biopsy and studies omparing PET\u002FCT guided and CT guided percutaneous transthoracic lung biopsy are very few and this study would be a randomized trial comparing these diagnostic modalities in terms of diagnostic yield, diagnostic accuracy of sample and complications.",[67],"Lung Diseases",[9,15,69],"Lung lesions","2025-04-04",{"date":72,"type":73},"2025-04-11","ACTUAL",{"date":75,"type":73},"2023-07-01",{"date":77,"type":61},"2025-12",{"name":5,"class":6},1]